NeoStem (NBS) Chinese Subsidiary Receives OK from China SFDA to Manufacture Penicilin
Tweet Send to a Friend
NeoStem, Inc. (AMEX: NBS) announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
